SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
441OT-Some of those are mine. Just setting up positions. At least my part of it ikenhott-5/7/2009
440Interesting action on Sept. calls and puts yesterday with 2300 12.5 calls and 27Steve Lokness-5/7/2009
439unless she heads back into the low 5's again, I would agree with your stratemopgcw-5/7/2009
438I actually now intend to wait until after Phase 2b results are announced before mcbio-5/7/2009
437Rigel Announces First Quarter 2009 Financial Results On Tuesday May 5, 2009, 7:0mopgcw-5/5/2009
436CS: Rigel Pharmaceuticals Inc. (RIGL) OUTPERFORM [V] M. Aberman CP: US$ 7.10 TP:mopgcw-5/5/2009
435Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas PR Newswiremopgcw-3/14/2009
434citi: Rigel Pharmaceuticals Inc (RIGL) Estimate change Y Non-eventful 4Q08 - Remopgcw-2/28/2009
433CS: Rigel Pharmaceuticals Inc. (RIGL) Outperform [V] M. Aberman CP: US$ 5.40 TP:mopgcw-2/24/2009
432Rigel Announces Fourth Quarter and Year End 2008 Financial Results Tuesday Februmopgcw-2/24/2009
431Shakespeare was right... Coughlin Stoia Geller Rudman & Robbins LLP Files Cmopgcw-2/10/2009
430SeekingAlpha: Rigel and Seattle Genetics: The Delicate Art of Expectation Managemopgcw-2/10/2009
429Thanks mcbio. I guess a lot of investors are angry with the company and ignore beta007-2/8/2009
428Welcome beta. I assume analysts still like it for the <b>longer-term</mcbio-2/8/2009
427Hi all, new to the board. If the company is dead money for 6 months, how come anbeta007-2/8/2009
426Totally agree on it being dead money for a few months. I don't expect it tomcbio-2/4/2009
425I agree it seems overly negative. The program seems less risky with the clean Qtuck-2/4/2009
424It seems a bit ridiculous to me to drop the price target from $34 to $16 just bemcbio-2/3/2009
423I sold my chunk today for veggie burger money after commissions. Seems like deatuck-2/3/2009
422CS: Rigel Pharmaceuticals Inc. (RIGL) Outperform [V] M. Aberman CP: US$ 7.17 TP:mopgcw-2/3/2009
421off the top of my head, I would be suprised if they are not munched by somebody,mopgcw-2/3/2009
420>>Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results Cotuck-2/3/2009
419>>Rigel to Host Conference Call on February 3, 2009 Last update: 2/2/2009 tuck-2/2/2009
418RBC downgraded RIGL on Friday from 'sector perform' to 'underperformmcbio-1/31/2009
417Thanks for that. I looked into the options just now. Indeed, the OI is highesttuck-1/27/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News